Clinipace Blog

Inc. Magazine Names Clinipace Worldwide to the Inc. 500 Annual List of America’s Fastest-Growing Private Companies

david.levin — Tue, 24 Aug 2010 18:35:51 +0000

Ranked 485, (and ranked 32nd in our industry) Clinipace is listed among the most successful private companies that have experienced substantial revenue growth over a three year period (2006-2009). As we’ve been preaching to all that will listen, this recognition confirms that Clinipace Worldwide is changing the face of global life science clinical research and development [...]

CED Names Clinipace Worldwide a North Carolina Company to Watch

david.levin — Wed, 28 Jul 2010 14:31:57 +0000

Great news for our employees, partners, and clients. Today we were named one of 25 North Carolina Companies to Watch by CED, a private, nonprofit organization that promotes entrepreneurial efforts in North Carolina. The inaugural class of North Carolina Companies to Watch represent growth-stage entrepreneurial companies that demonstrate high performance in the marketplace, exhibit [...]

Successful transformations are always led by people, no different in clinical research

david.levin — Tue, 27 Jul 2010 15:42:44 +0000

Transforming the Way Project Teams Function In the dCRO, clinical research and operations software (that is, “eClinical”) integrates in one platform the spectrum of clinical trials functions including Project Management, Data Management, Monitoring, and Data Analysis and Reporting. With the aid of collaborative technology, every stakeholder involved in a project works around the same hub, uses [...]

Trials in Latin America

david.levin — Tue, 13 Jul 2010 18:41:44 +0000

One of today’s most important emerging regions for clinical trials is Latin America, which is being increasingly considered for trials because it offers significant potential. Regulatory enforcement bodies, quality investigators, ethics committees ensuring patient safety, proactive Good Clinical Practice (GCP) policy development, and huge research naïve populations have been cited as contributing to Latin America’s explosive [...]

Benefits of the technology-fueled transformation of #clinicaltrial operations

david.levin — Tue, 13 Jul 2010 18:30:47 +0000

[This post is the third in a three-part series about the transformations occurring throughout the clinical research industry and Clinipace Worldwide's effort to bring more efficiency and transparency to the process.] As a result of the digital Clinical Research Organization transformation, clinical trials have better quality control, run with enhanced efficiency, greater transparency, and at reduced [...]

Clinipace Worldwide ranked #7 on Top 100 North Carolina Small Business list

david.levin — Fri, 25 Jun 2010 19:59:08 +0000

Based on our tremendous growth in new clients and projects over the past few years Clinipace Worldwide, a global full-service CRO, has been recognized as a Top 100 North Carolina Small Business for 2010 by Business Leader magazine, a leading business publication focused on the companies, leaders and trends in the North Carolina business community. Clinipace [...]

Tchotchkes at #ASCO in short supply (or demand)

david.levin — Tue, 08 Jun 2010 17:18:52 +0000

Thought you’d enjoy this quick read. State bans on physician gifts impacting conference goodies. At DIA next week, we’re giving $10 iTunes cards, but will make sure not to hand them out to practicing physicians, just to be safe From today’s FiercePharma newsletter… You’ve heard that there’s no free lunch, but no free coffee? One [...]

The rise of the digital clinical research organization (dCRO), part two

david.levin — Thu, 03 Jun 2010 21:51:12 +0000

[This post is the second in a three-part series about the transformations that are occurring throughout the clinical research industry and Clinipace Worldwide's effort to bring more efficiency and transparency to the process.] The new clinical research paradigm is characterized by a unified technology that enables integration, collaboration, and transparency across all stakeholders: integration and collaboration [...]

Cash for research, we hope young companies take advantage

david.levin — Tue, 25 May 2010 18:12:41 +0000

On Friday, the US Treasury released details about its Therapeutic Discovery Project Program, which was created by the Affordable Care Act to support small pharmaceutical and biopharmaceutical companies’ research efforts. The program’s goals are to promote the development of new therapies, create US jobs, and increase US firms’ competitiveness. Story originally reported at http://blog.pharmtech.com/2010/05/24/the-us-treasury-shows-rd-scientists-some-love/

Vaccinogen Selects Clinipace Worldwide to Manage Global Phase 3b Clinical Trial

david.levin — Wed, 05 May 2010 13:41:18 +0000

This morning we announced that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body’s own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX® in the treatment of Stage II Colon Cancer. With colon cancer being the third most common [...]